Geert Vandeweyer

7PUBLICATIONS
26CO-AUTHORS
Molecular targetsPlant physiologyCancer cell biologyGene mappingEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 24, 2026
In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses.

|Jun 16, 2025
Unveiling the Mechanistic Impact of Mutations F2004C/V in the ROS1 Kinase Domain.

Juliana F Vilachã, Farhan Ul-Haq, Geert Vandeweyer

|Mar 03, 2024
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles.

Marc Terrones, Christophe Deben, Felicia Rodrigues-Fortes

|Feb 21, 2020
Osmotic stress inhibits leaf growth of Arabidopsis thaliana by enhancing ARF-mediated auxin responses.

Shweta Kalve, Bulelani L Sizani, Marios Nektarios Markakis

|Dec 22, 2019
The roles of patient groups in fostering cancer research.

Merel Hennink, Geert Vandeweyer, Janet Freeman-Daily

|Apr 11, 2019
Insufficient evidence for a role of SERPINF1 in otosclerosis.

Hanne Valgaeren, Manou Sommen, Matthias Beyens

Pageof 2

Frequent Collaborators

1 joint publications

R Frank Kooy

1 joint publications

Hanne Valgaeren

1 joint publications

Manou Sommen

1 joint publications

Matthias Beyens